Blake Lapthorn's Biotechnology and Pharamceuticals team has
advised companies across a wide range of industry sectors,
including:
- a large UK biotech in-licensing compound libraries from a major
pharmaceutical company including options covering co-development,
co-marketing, development opt outs and variable downstream
milestones and other payments
- a UK biotech on collaboration with a US biotech involving
target identification and validation together with further
development and subsequent cross licensing
- a UK biotech on a long-term collaboration with a US biotech
involving target identification and validation together with joint
international clinical trials, development opt outs, up-front and
downstream milestones and other payments
- a UK biotech on a major academic collaboration involving
out-licensing, employee secondment and PhD sponsorship
